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Abstract
Background: An impressive number of dental implants are inserted worldwide. Evolution in dental implants and simplification of surgical 
techniques allowed a significant increase in the number of dentists involved in implant surgery. Most of them are general dentists, are not 
always sufficiently formed and experienced, frequently use low‑quality implants, do not adopt the proper patient selective criteria, do not 
adequately monitor and maintain the inserted implants, and do not report their own statistics to the dental community. Consequently, 
the incidence of inflammatory periimplant diseases (IPDs) has progressively increased to values significantly higher than those previously 
indicated by the scientific literature. Materials and Methods: Two main literature searches were undertaken in October 2018 in the PubMed 
Website database. Only articles written in English and published from 2008 onward were considered; “Clinical Trial,” “Meta analysis,” 
“Observational study,” “Review,” and “Validation study” were selected as article type filters. The following keywords were used in the 
searches: “Peri implantitis prevention” and “Dental implant failure prevention.” Results: Preventive measures are analyzed according 
to the different factors that can favor the occurrence of an infection. The factors are divided into (i) implant dependent, (ii) patient 
dependent, and (iii) surgeon dependent. Conclusions: Scientific and clinical data confirm that when materials are selected with care, 
patients are carefully evaluated for factors of risk and attitude to adhere to the necessary maintenance program, and operative protocols 
and maintenance programs are respected dental implants can be attractive and effective tools for oral rehabilitation. Nevertheless, dentists 
and patients should have greater awareness that in many cases the decision to utilize dental implants cannot be taken lightly.
Keywords: Periimplantitis, Periimplant Mucositis, Prevention
IntroductIon
Implant dentistry has emerged during the last decades 
as one of the most successful techniques for oral 
rehabilitation.[1‑5] Modern oral implants, if  adequately 
inserted and maintained in rigorously selected and 
instructed patients, guarantee high success rates 
and long‑term survival, although they can undergo 
inflammatory periimplant diseases (IPDs) and fail.[1,6‑12]
In a recent review focusing at the evolution of implant 
dentistry and its future perspectives, Buser et al.[1] properly 
evidenced that the picture suggested “by professional 
boards of periodontists that the incidence of biologic 
complications, and more specifically of peri‑implantitis, 
may be up to 50%, has shaken the dental community” 
and “holds a certain risk of damage to the reputation of 
implant dentistry.”
According to the same authors, “the high prevalence of 
peri‑implantitis reported by some authors is related to a 
scientific flaw.” Nevertheless, daily clinical experience and 
several reports from the literature, which will be analyzed 
further in this article, indicate that the clinical relevance of 
IPD is underestimated as a consequence of different factors.
Success rates of dental implants are generally estimated 
according to results obtained by university‑based groups 
with high clinical experience, performing maintenance 
and follow‑up programs.[2‑5]
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During the last 10–15  years, the number of dentists 
involved in implant surgery has progressively expanded, 
with a significant increase of the number of general 
dentists who, in many cases, are not provided with specific 
clinical training and adequate skill and experience.[13,14] 
Data of the literature show that when dental implants 
are positioned by dentists lacking diagnostic and 
clinical experience, training, and specific skills, they have 
significantly higher failure rates.[15‑18]
The same period witnessed, at least in Europe, an 
exponential diffusion of the so‑called “low‑cost dental 
clinics” that, in many cases, found their expectation of 
commercial success on dental implant–based rehabilitations.
As most general dentists and those who work in 
“low‑cost dental clinics” seldom perform dental implant 
maintenance programs and long‑term follow‑up of 
patients, and generally do not publish their own statistics 
in scientific journals, failures due to IPD in these cases are 
largely misunderstood.
Moreover, it must be considered that most of the studies 
performed in the past evaluated clinical outcomes of 
dental implants based on survival rates, and assumed that 
an implant is not failed until it is functionally valid.[2‑5,10‑
12] Such an approach is misleading: in fact, a surviving 
implant is not necessarily a healthy implant.[19‑22]
Recent reports show that when functionally valid 
implants (i.e., dental implants loaded with a prosthesis 
in the absence of subjective symptoms and functional 
limitations) are examined for conditions of periimplant 
tissues, the prevalence of periimplantitis results as high 
as about 35% at the patient level and about 20% at the 
implant level.[23‑25]
Once considered that only two main causes of progressive 
periimplant bone resorption have been extensively 
investigated in the past (i.e., functional overload and 
infection), and that at present most authors consider that 
the role of overload (in the absence of inflammation) 
has been largely overestimated[26,27], it must be concluded 
that periimplantitis is by far the most relevant menace 
to periimplant tissue health[6,7,28] and that concrete, 
coordinate measures should be adopted in everyday 
practice to effectively reduce its incidence.
MaterIals and Methods
This non‑systematic review intended to analyze selected 
literature reports dealing with technical and clinical 
procedure having an influence on the prevention of IPD 
in order to give the reader synthetic and updated key 
information ready to be applied to daily clinical practice 
and to perform implant dentistry with high probability of 
long‑term success.
It was consequently decided to perform literature searches 
using only general terms expected to be as inclusive 
as possible. Such an approach could have limited the 
possibility to retrieve articles dealing with very specialized 
aspects of the argument and with basic science knowledge, 
which nevertheless were not within the aims of this review 
article.
Two main literature searches were undertaken in October 
2018 in the PubMed Website database. Only articles 
written in English and published from 2008 onward 
were considered; “Clinical Trial,” “Meta analysis,” 
“Observational study,” “Review,” and “Validation 
study” were selected as article type filters. The following 
keywords were used in the searches: “Peri implantitis 
prevention” and “Dental implant failure prevention.” The 
two searches retrieved 213 and 159 articles, respectively, 
including several replicates. A first selection was made by 
the authors by reading the titles and abstracts from these 
results to identify articles dealing with the selected topics 
of this review. For articles appearing to be of interest, or 
for which the title and abstract did not allow to make a 
clear decision, the full report was assessed. In this way, 
123 articles were selected overall. Reference lists of these 
articles were hand‑searched for additional articles.
The last complementary checkup for newly published 
articles within the topic was performed in April 2019.
dIscussIon
IPDs are bacterially driven inflammatory processes that 
can be favored by different factors, thus requiring an 
articulated net of preventive measures to be carefully 
adopted. These factors can be divided into (i) implant 
dependent, (ii) patient dependent, and (iii) surgeon 
dependent.
Implant-dependent factors
At present, a plethora of different dental implant systems 
are available worldwide. Only in Italy, about 60 dental 
implant manufacturers are active and in several cases these 
implants are inadequately designed and poorly controlled.
Studies performed between the middle 1980s of the last 
century and the beginning of the new millennium allowed 
to identify moderately rough titanium surfaces as the 
gold standard for optimal osseointegration.[1,29‑32] The 
growing need for multiple prosthetic connection solutions 
determined success of the two‑piece implant systems, 
although creation of the implant–abutment interface 
(IAI) revealed risky by enabling bacteria to penetrate 
inner parts of the implant, which can act as an infective 
reservoir to promote IPD.[33‑35]
Although internal hexagon connections characterizing 
modern implants make the IAI less accessible to bacteria, and 
although the introduction of conical connections enabled to 
significantly reduce gap dimensions at the IAI,[36] all types of 
connections, when tested under charge or evaluated clinically, 
show some degree of bacterial microleakage.[37,38]
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Experimental data show that bacterial microleakage 
is inversely proportional to torque used to tighten the 
abutment,[36,39] and that abutments made of zirconia[40] and 
castable abutments[41] enhance the risk. It can consequently 
be concluded that titanium‑to‑titanium pre‑machined 
abutments should be privileged.
The region where fixture, abutment, and prosthesis meet 
is a very delicate one: different materials come in intimate 
contact in direct proximity to the place where gingival 
epithelium, connective tissue, and bone work together 
to repair/maintain tissue integrity. Such a variety of 
juxtaposed surfaces is very attractive for many different 
bacterial species, thus contributing to enhance infective 
risk.[42]
It is not by chance that a lot of work was performed to 
understand the histological characteristics of periimplant 
marginal tissues and to optimize/modify the implant collar 
so that marginal bone is preserved and bacterial biofilm 
formation is minimized. Moderately rough titanium 
surfaces play an osteoconductive role and undergo 
optimal osseointegration without enhancing bacterial 
biofilm accumulation.[43] Rough titanium collars minimize 
marginal bone remodeling[44] and promote bone and soft 
connective tissue formation.[45] Marginal bacterial biofilm 
accumulation is undoubtedly the necessary condition for 
IPD initiation and the possibility for bacteria to access 
intra‑implant reservoirs is probably the way they use to 
have an easier access to marginal bone.
Different strategies to reduce the susceptibility of 
dental implants to bacterial colonization have been 
investigated. Laser ablation of titanium implant surfaces 
was shown to reduce the amount of biofilm formed by 
different pathogens as compared to sandblasted titanium 
surfaces.[46] Anatase‑coated implant collars were shown to 
reduce marginal bone loss and to prevent colonization by 
Tannerella forsythia, as compared to standard implants.[47]
Bacterial biofilms formed in a 96‑hour time course on 
titanium discs coated with zinc oxide or zinc oxide and 
hydroxyapatite nanoparticles were reduced in mass and 
viability as compared to uncoated titanium.[48]
Glassy coatings enriched with antimicrobials significantly 
reduced bacterial colonization of the surfaces and bone 
loss in an experimentally induced periimplantitis animal 
model.[49]
Shahi et  al.[50] immobilized tetracycline‑containing 
fibers at the surface of implants obtaining a significant, 
although transient, antibacterial activity.[50] Wang et al.[51] 
developed a silica‑based gentamicin nanodelivery system 
cross‑linked to oxidized titanium.
Binding of bioactive peptides to titanium is being actively 
investigated to obtain long‑lasting antibacterial activity 
and to speed up osseointegration processes in the absence 
of toxic effects.[52,53]
Considered that IPDs are sustained by different 
microorganisms and characterized by different pathogenic 
mechanisms, it seems reasonable that the aforementioned 
strategies, once validated and appropriately coupled, 
could prove effective in reducing the incidence of IPD, 
and that implants with functionalized surfaces could be 
the materials of choice for cases characterized by relevant 
factors of risk.
Patient-dependent factors
The decision to submit a patient to a dental implant–
supported rehabilitation should carefully consider factors 
relevant for the onset of IPD: (i) predisposing and risk 
conditions, and (ii) patient’s care and attitude for oral 
hygiene.
Several authors addressed the question of risk factors 
and their relative and cumulative relevance in the decision 
process.[54‑56]
The question whether a history of periodontal disease is 
a factor of risk for IPD or not is crucial and has been 
extensively debated in the literature and deserves special 
attention because periodontitis is a highly prevalent cause 
of partial/total edentulism (i.e., the condition that gives 
indication to implant‑based rehabilitation).[57‑59]
Most authors agree that a previous history of 
periodontitis is a factor of  risk for IPD,[54‑56,60] and 
epidemiologic data indicate that patients with a history of 
periodontitis have a higher prevalence of  periimplantitis 
than healthy patients,[54] but the underlying mechanisms 
are not well defined. The assumption that the pathogenic 
microbiome of periodontally affected sites diffuses 
to the periimplant environment causing IPD is not 
scientifically supported. In patients treated for aggressive 
periodontitis, periodontal pathogens can colonize the 
periimplant environment in the absence of  IPD.[61] The 
microbiomes of  adjacent periodontal and implanted sites 
are characterized by low degrees of  congruence, and only 
a minority of  dental implants adjacent to periodontal 
sites positive for putative pathogens included in the red 
complex resulted positive for the same microorganisms, 
with the most abundant species in the two environments 
being constantly distinct.[62]
Recent studies show that patients with a previous history 
of periodontal disease are less compliant to maintenance 
programs and oral hygiene measures than healthy 
subjects, and that consequently a history of periodontitis 
and its severity are factors influencing the compliance risk 
profile.[63]
Success rates for dental implants are influenced also by 
specific site‑related factors including the periodontal 
condition and the level of bone crest in relation to the 
cementoenamel junction of adjoining teeth at the time of 
restoration. Interestingly, the risk associated with insertion 
of an implant adjacent to a periodontally affected tooth 
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results significantly higher than the one associated with a 
generic history of periodontitis (odds ratios 8.0 and 2.4, 
respectively).[64]
Overall, when periodontal disease is considered as a risk 
factor in the implant decision‑making process, it cannot be 
considered as a static factor but it should be rather related 
to a number of other parameters including patient’s 
hygienic attitude and understanding of the relevance of 
maintenance, site‑specific conditions, and the conditions 
of adjoining teeth.
Even in the absence of periodontal disease, inadequate 
oral hygiene and the presence of abundant dental biofilm 
are factors of risk for IPD.[65] Patients with good oral 
hygiene develop IPD if  implants are positioned so that 
their hygienic maintenance is difficult.[66]
A monocentric clinical study on 2673 implants in 1427 
patients followed for a mean of 5.3 years showed a statistically 
significant association between secondary failures due to 
periimplantitis and individual attitude to oral hygiene.[67]
Cigarette smoking is considered by most authors as a 
major factor of risk for IPD.[56,68] Negative effects of 
cigarette smoking are dose dependent, and smokers were 
estimated to have up to a three to four folds higher risk of 
developing periimplantitis than nonsmokers,[69] associated 
with significant differences in the two microbiomes.[70] 
Patients should consequently be encouraged to stop/
reduce smoking before implant therapy.
The role of alcohol consumption as a risk factor for 
dental implants is controversial. Several clinical studies 
addressed this question but only a minority of them 
identified alcohol consumption as an evident factor of 
risk.[71‑73] Unlike smoking and alcohol abuse, alcohol 
consumption is an extremely variable behavior (frequency, 
type, amount), and these variables are not constantly and 
univocally considered in the literature.
An experimental study in rats showed that prolonged 
and excessive alcohol intake significantly impaired 
osseointegration of titanium dental implants inserted in 
the femur. [74]
In a recently published review, the authors put in evidence 
that heavy alcohol consumption exacerbates the effects 
of tobacco.[75] On the basis of available data, it appears 
reasonable to suggest caution in inserting dental implants 
in heavy alcohol consumers/abusers.
The role of diabetes as a factor of risk for IPD is widely 
debated. A recently published systematic review, specifically 
addressing this question, concluded that adequately 
controlled diabetes is not a factor of risk, whereas poor 
glycemic control favors impaired osseointegration, 
elevated risk of IPD, and implant failure.[76]
According to a meta‑analysis performed by Monje et al., 
patients with diabetes have a 50% higher risk to develop 
periimplantitis, but not periimplant mucositis and, when 
only nonsmokers are considered, diabetic patients with 
hyperglycemia have a 3.39‑fold higher risk for periimplantitis 
as compared to those with normal glycemia.[77]
In spite of a number of studies performed in different 
geographic areas, no substantial convergence on worldwide 
diffused gene polymorphisms correlated to an enhanced 
risk of IPD was evidenced.[78,79]
The potential risk associated with the occurrence of 
osteonecrosis of the jaw following implant therapy in 
subjects assuming bisphosphonates has been the object of 
intense debate in recent years.
Although bisphosphonate treatment is certainly associated 
with an increased incidence of osteonecrosis of the jaws, 
the role of dental implants as a trigger for this relevant 
complication is still uncertain. A  recent review on this 
topic concluded that patients under oral bisphosphonate 
therapy can be submitted to dental implant therapy, 
provided all other concurring conditions of risk (age, 
diabetes, obesity, smoking, immunosuppressive therapies, 
poor oral hygiene) are carefully evaluated.[80]
Surgeon-dependent factors
The last two decades witnessed a significant evolution in 
implant materials and surgical procedures that have made 
implant insertion progressively easier, thus enlarging the 
number of dentists performing implant surgery. Although 
it is reasonable that simplified surgical procedures could 
have positively affected early outcomes of implant 
surgery, they have certainly contributed to reduce the 
mean experience of operators.
It is generally agreed that the learning curve of each 
surgeon is characterized by higher failure rates as 
compared to later periods.[17,81] The impact of human 
factors on dental implant success is intuitive and was 
clearly demonstrated by monocentric studies evaluating 
the outcome of all implants placed during a period of time 
in a single clinical center.[51,82,83] Albrektsson[82] showed that 
one single surgeon, although experienced, was responsible 
for the majority of failed implants within the studied 
clinical center.
Studying a sample of 9582 implants consecutively placed 
between 2003 and 2011 during 3448 implant operations 
at one clinic, and followed up to end of 2015, Jemt[83] 
observed that implant failures were associated to four 
significant factors, with the surgeon showing the highest 
impact on risk (hazard ratio = 2.50).[83]
Surgeon‑dependent factors do not end with experience 
and adherence to protocols. The surgeon is responsible for 
patient selection and motivation, for surgical planning, for 
implant placement, and follow‑up; he must interface with 
the prosthodontist and the oral hygienist for long‑term 
maintenance of implants.
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Perioperative antibiotic prophylaxis addresses only early‑
onset infections, whose incidence is low; consequently, 
the influence of antibiotic prophylaxis on success rates is 
minimal. At present, there are no established guidelines 
for antibiotic prescription in dental implant surgery. An 
investigation performed in Spain revealed that there is 
no consensus regarding antibiotic prophylaxis in implant 
dentistry and that the most commonly prescribed regimens 
are different from those recommend in the literature.[84]
Available data indicate that a single dose of 2 g of 
amoxicillin administered 1 hour before surgery is the 
regimen of choice for dental implant surgery with no need 
of further postoperative doses.[9,85]
Long‑term prevention of IPD requires a patient‑
specific maintenance program aimed at maintaining a 
healthy periimplant mucosa and promptly treating sites 
where periimplant mucositis occurs.[86] Dental implant 
maintenance should include optimized daily oral hygiene, 
periodic implant examination and reevaluation of patient‑
specific risk factors, and periodic professional oral 
hygiene maintenance. Maintenance programs should be 
individually designed with a recall period not exceeding 
6 months even in healthy, compliant patients.[63]
conclusIon
Dental implants are attractive and effective tools for 
oral rehabilitation, but dentists and patients should have 
greater awareness that in many cases the decision to utilize 
them cannot be taken lightly. Patients should be carefully 
evaluated for factors of risk and attitude to adhere to 
the necessary maintenance program. Dentists should 
carefully select materials, respect operative protocols, and 
constantly communicate with their staff  to prevent IPD 
and periimplant tissue damage.
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